| 1 |
William H. Geissele |
Whg Properties |
34 |
| 2 |
Scott D. Kuduk |
Merck |
19 |
| 3 |
Bernard Scallon |
Johnson & Johnson |
5 |
| #4 |
David Shealy |
Johnson & Johnson |
4 |
| #4 |
Raymond Sweet |
Johnson & Johnson |
4 |
| #6 |
Douglas C. Beshore |
Merck |
3 |
| #6 |
Sheng-Jiun Wu |
Johnson & Johnson |
3 |
| #8 |
Alexey Teplyakov |
Johnson & Johnson |
2 |
| #8 |
Mark Cunningham |
Johnson & Johnson |
2 |
| #8 |
Joseph H. Gorman, III |
University of Pennsylvania |
2 |
| #8 |
Thomas Malia |
Johnson & Johnson |
2 |
| #12 |
Monica Goldberg |
Johnson & Johnson |
1 |
| #12 |
Peter T. BUCKLEY |
New York University |
1 |
| #12 |
Melissa Murdock |
Johnson & Johnson |
1 |
| #12 |
Keri Dorn |
New York University |
1 |
| #12 |
Michelle Kinder |
New York University |
1 |
| #12 |
Vedrana Stojanovic-Susulic |
Applied Molecular Evolution |
1 |
| #12 |
Anthony Lynch |
New York University |
1 |
| #12 |
Francois Gaudet |
Johnson & Johnson |
1 |
| #12 |
Alan C. Gibbs |
Johnson & Johnson |
1 |
| #12 |
Christopher Alderfer |
Johnson & Johnson |
1 |
| #12 |
Xuqing Zhang |
Johnson & Johnson |
1 |
| #12 |
Jose Pardinas |
Signal Pharmaceuticals |
1 |
| #12 |
Brian Whitaker |
Johnson & Johnson |
1 |
| #12 |
Anderson Mark |
Johnson & Johnson |
1 |